Description
Mazdutide 10 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product on this listing.
Research-grade synthetic peptide supplied as a 10 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
This vial is not semaglutide, tirzepatide, survodutide or retatrutide and is not a UK authorised medicine.
Identification
| Product name | Mazdutide |
| Also listed as | IBI362; LY3305677 |
| Research class | Dual glucagon / GLP-1 receptor analogue (research ligand) |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg per vial |
| CAS | 2259884-03-0 |
| Approx. mass | ~4563 Da |
| Intended use | Laboratory / in-vitro research only |
Confirm identity on the lot COA.
Quality / storage
Only the lot COA applies. Store as a laboratory peptide under institutional SOP. No pen, dose or injection instructions on this page.
Published research context (not product claims)
Mazdutide is a glucagon/GLP-1 receptor dual analogue from Innovent / Lilly chemistry (IBI362 / LY3305677). Receptor papers describe dual-agonist pharmacology in experimental systems.
Clinical-development and overseas-authorisation publications concern regulated drug products in those programmes. They do not authorise sale of this research vial as a UK medicine.
Foreign approvals, if any, apply only to approved presentations. They must not be rewritten as weight-loss claims for this listing.
There is no MHRA marketing authorisation for this vial.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.